Korpela M - Search Results

1

Intermittent interferon and polychemotherapy in metastatic melanoma.

Vuoristo MS, Gröhn P, Kellokumpu-Lehtinen P, Kumpulainen E, Turunen M, Korpela M, Joensuu H, Tiusanen K, Nevantaus A. Vuoristo MS, et al. Among authors: korpela m. J Cancer Res Clin Oncol. 1995;121(3):175-80. doi: 10.1007/BF01198100. J Cancer Res Clin Oncol. 1995. PMID: 7536196 Clinical Trial.

2

A phase II study of metastatic melanoma treated with a combination of interferon alfa 2b, dacarbazine and nimustine.

Gröhn P, Kumpulainen E, Nuortio L, Hakala T, Vuoristo MS, Korpela M, Heikkinen M, Salmi R, Jakobsson M, Numminen S. Gröhn P, et al. Among authors: korpela m. Eur J Cancer. 1992;28(2-3):441-3. doi: 10.1016/s0959-8049(05)80072-3. Eur J Cancer. 1992. PMID: 1591060 Clinical Trial.

3

Serum matrix metalloproteinase-2 as a prognostic marker in advanced cutaneous melanoma.

Vuoristo MS, Kellokumpu-Lehtinen P, Parvinen LM, Hahka-Kemppinen M, Korpela M, Kumpulainen E, Laine S. Vuoristo MS, et al. Among authors: korpela m. Acta Oncol. 2000;39(7):877-9. doi: 10.1080/028418600750063659. Acta Oncol. 2000. PMID: 11145448

4

Serum adhesion molecules and interleukin-2 receptor as markers of tumour load and prognosis in advanced cutaneous melanoma.

Vuoristo MS, Laine S, Huhtala H, Parvinen LM, Hahka-Kemppinen M, Korpela M, Kumpulainen E, Kellokumpu-Lehtinen P. Vuoristo MS, et al. Among authors: korpela m. Eur J Cancer. 2001 Sep;37(13):1629-34. doi: 10.1016/s0959-8049(01)00192-7. Eur J Cancer. 2001. PMID: 11527688

5

Treatment of patients with metastatic melanoma with a one day regimen of dacarbazine, vincristine, bleomycin and lomustine plus interferon-alpha.

Vuoristo M, Gröhn P, Kumpulainen E, Korpela M. Vuoristo M, et al. Among authors: korpela m. Eur J Cancer. 1994;30A(3):420. doi: 10.1016/0959-8049(94)90278-x. Eur J Cancer. 1994. PMID: 7515632 Clinical Trial. No abstract available.

6

The value of serum S-100beta and interleukins as tumour markers in advanced melanoma.

Vuoristo MS, Kellokumpu-Lehtinen P, Laine S, Parvinen LM, Hahka-Kemppinen M, Korpela M, Kumpulainen E. Vuoristo MS, et al. Among authors: korpela m. Melanoma Res. 2000 Jun;10(3):237-41. Melanoma Res. 2000. PMID: 10890377 Clinical Trial.

7

[Methotrexate in the treatment of rheumatoid arthritis].

Korpela M. Korpela M. Duodecim. 1996;112(19):1830-5. Duodecim. 1996. PMID: 10596184 Review. Finnish. No abstract available.

8

Effect of a three month course of ciprofloxacin on the outcome of reactive arthritis.

Yli-Kerttula T, Luukkainen R, Yli-Kerttula U, Möttönen T, Hakola M, Korpela M, Sanila M, Parviainen J, Uksila J, Vainionpää R, Toivanen A. Yli-Kerttula T, et al. Among authors: korpela m. Ann Rheum Dis. 2000 Jul;59(7):565-70. doi: 10.1136/ard.59.7.565. Ann Rheum Dis. 2000. PMID: 10873968 Free PMC article. Clinical Trial.

9

Mesangial glomerulopathy in rheumatoid arthritis patients. Clinical follow-up and relation to antirheumatic therapy.

Korpela M, Mustonen J, Pasternack A, Helin H. Korpela M, et al. Nephron. 1991;59(1):46-50. doi: 10.1159/000186516. Nephron. 1991. PMID: 1944747

10

Diagnostic accuracies of plasma creatinine, cystatin C, and glomerular filtration rate calculated by the Cockcroft-Gault and Levey (MDRD) formulas.

Harmoinen A, Lehtimäki T, Korpela M, Turjanmaa V, Saha H. Harmoinen A, et al. Among authors: korpela m. Clin Chem. 2003 Jul;49(7):1223-5. doi: 10.1373/49.7.1223. Clin Chem. 2003. PMID: 12816933 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

180 results

Search Page

Filters